Vicente, Phebe A.

HRN: 00-97-92  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/18/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
04/18/2025
04/25/2025
IV
4.5gm LD Then 2.25gm Q8h
Q8h
CAP MR, SEPSIS
Waiting Final Action 
04/18/2025
AZITHROMYCIN 500MG TABLET (TAB)
04/18/2025
04/23/2025
PO
500mg
OD
CAP MR
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: